TMEM69
gene geneOn this page
Also known as FLJ21029
Summary
TMEM69 (transmembrane protein 69, HGNC:28035) is a protein-coding gene on chromosome 1p34.1, encoding Transmembrane protein 69 (Q5SWH9).
Located in mitochondrion.
Source: NCBI Gene 51249 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_016486
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28035 |
| Approved symbol | TMEM69 |
| Name | transmembrane protein 69 |
| Location | 1p34.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ21029 |
| Ensembl gene | ENSG00000159596 |
| Ensembl biotype | protein_coding |
| Entrez | 51249 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 16 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000372025, ENST00000496366, ENST00000871190, ENST00000871191, ENST00000871192, ENST00000871193, ENST00000871194, ENST00000871195, ENST00000871196, ENST00000871197, ENST00000937789, ENST00000937790, ENST00000937791, ENST00000937792, ENST00000937793, ENST00000937794, ENST00000960165
RefSeq mRNA: 1 — MANE Select: NM_016486
NM_016486
CCDS: CCDS41325
Canonical transcript exons
ENST00000372025 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001456726 | 45693204 | 45694436 |
| ENSE00001456727 | 45690974 | 45691110 |
| ENSE00001923758 | 45688181 | 45688275 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 98.28.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 49.6438 / max 313.1952, expressed in 1818 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2705 | 47.1004 | 1817 |
| 2704 | 2.5434 | 754 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 98.28 | gold quality |
| secondary oocyte | CL:0000655 | 98.18 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 96.29 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 94.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.74 | gold quality |
| gingival epithelium | UBERON:0001949 | 93.59 | gold quality |
| myocardium | UBERON:0002349 | 93.11 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.73 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 92.55 | gold quality |
| rectum | UBERON:0001052 | 92.38 | gold quality |
| ileal mucosa | UBERON:0000331 | 92.28 | gold quality |
| gingiva | UBERON:0001828 | 92.28 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 92.13 | gold quality |
| vastus lateralis | UBERON:0001379 | 92.03 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 91.97 | gold quality |
| quadriceps femoris | UBERON:0001377 | 91.81 | gold quality |
| deltoid | UBERON:0001476 | 91.73 | gold quality |
| penis | UBERON:0000989 | 91.53 | gold quality |
| biceps brachii | UBERON:0001507 | 91.31 | gold quality |
| monocyte | CL:0000576 | 91.12 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.08 | gold quality |
| leukocyte | CL:0000738 | 90.96 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 90.67 | gold quality |
| esophagus mucosa | UBERON:0002469 | 90.64 | gold quality |
| cortical plate | UBERON:0005343 | 90.50 | gold quality |
| right adrenal gland | UBERON:0001233 | 90.39 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 90.23 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 90.22 | gold quality |
| metanephros | UBERON:0000081 | 90.13 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 89.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.23 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): GLI1
miRNA regulators (miRDB)
42 targeting TMEM69, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-3681-5P | 99.82 | 66.88 | 387 |
| HSA-MIR-139-5P | 99.80 | 69.50 | 1399 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-6849-5P | 99.64 | 66.00 | 352 |
| HSA-MIR-802 | 99.61 | 67.70 | 1254 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-12117 | 99.50 | 67.57 | 868 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-143-3P | 99.49 | 69.05 | 1457 |
| HSA-MIR-4770 | 99.49 | 69.09 | 1451 |
| HSA-MIR-6088 | 99.29 | 68.45 | 1284 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem69 | ENSDARG00000076017 |
| mus_musculus | Tmem69 | ENSMUSG00000055900 |
| rattus_norvegicus | Tmem69 | ENSRNOG00000029152 |
Protein
Protein identifiers
Transmembrane protein 69 — Q5SWH9 (reviewed: Q5SWH9)
All UniProt accessions (1): Q5SWH9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_057570* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021836 | DUF3429 | Family |
Pfam: PF11911
UniProt features (7 total): transmembrane region 5, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5SWH9-F1 | 73.68 | 0.40 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 108 (showing top):
AAAYRNCTG_UNKNOWN, YY1_Q6, MYOD_01, chr1p34, LYF1_01, DODD_NASOPHARYNGEAL_CARCINOMA_UP, RYTTCCTG_ETS2_B, YY1_01, ACTWSNACTNY_UNKNOWN, GCCATNTTG_YY1_Q6, MYB_Q6, SMAD4_Q6, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): mitochondrion (GO:0005739), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
488 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM69 | GPBP1L1 | Q9HC44 | 741 |
| TMEM69 | CCDC137 | Q6PK04 | 649 |
| TMEM69 | ZC3H10 | Q96K80 | 601 |
| TMEM69 | CBLN3 | Q6UW01 | 581 |
| TMEM69 | CLEC19A | Q6UXS0 | 549 |
| TMEM69 | C1QTNF7 | Q9BXJ2 | 531 |
| TMEM69 | PECR | Q9BY49 | 521 |
| TMEM69 | DNLZ | Q5SXM8 | 479 |
| TMEM69 | ENTR1 | Q96C92 | 477 |
| TMEM69 | METAP1 | P53582 | 476 |
| TMEM69 | TXNDC12 | O95881 | 473 |
| TMEM69 | LRRC20 | Q8TCA0 | 464 |
| TMEM69 | MRGPRX3 | Q96LB0 | 464 |
| TMEM69 | PURG | Q9UJV8 | 464 |
| TMEM69 | MAST2 | Q6P0Q8 | 461 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TUSC5 | TMEM69 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM69 | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP6 | TMEM69 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM69 | ACOX3 | psi-mi:“MI:0914”(association) | 0.350 |
| TUSC5 | TMEM69 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM14B | TMEM69 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM69 | AQP6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM69 | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (20): TMEM69 (Two-hybrid), TMEM69 (Two-hybrid), TUSC5 (Two-hybrid), IMPACT (Affinity Capture-MS), ACOX3 (Affinity Capture-MS), PKLR (Affinity Capture-MS), PBK (Affinity Capture-MS), KLK3 (Affinity Capture-MS), PRTN3 (Affinity Capture-MS), PPP2CA (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), RTFDC1 (Affinity Capture-MS), SMEK1 (Affinity Capture-MS), TPP2 (Affinity Capture-MS), S100A2 (Affinity Capture-MS)
ESM2 similar proteins: A1XQS5, A6H666, A8XDX2, B0VYY5, B3DHU2, G5EDB8, O14046, P00842, P05496, P07926, P10175, P11432, P16000, P16221, P17605, P23968, P32876, P48201, P48772, P56383, P56384, Q01931, Q03672, Q06055, Q06056, Q06645, Q06646, Q0V9J0, Q0VCH8, Q2LCR3, Q2TA24, Q37315, Q3ZC75, Q53CG1, Q59550, Q5RAP9, Q5RFL2, Q5SWH9, Q71S46, Q7JX57
Diamond homologs: Q0V9J0, Q3KQJ0, Q5SWH9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
358 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:45688259:TCTCA:T | donor_gain | 0.9800 |
| 1:45693198:TTGTA:T | acceptor_loss | 0.9800 |
| 1:45693199:TGTAG:T | acceptor_loss | 0.9800 |
| 1:45693201:TA:T | acceptor_loss | 0.9800 |
| 1:45693202:A:AG | acceptor_gain | 0.9800 |
| 1:45693202:AGAT:A | acceptor_loss | 0.9800 |
| 1:45693203:G:C | acceptor_loss | 0.9800 |
| 1:45693203:G:GG | acceptor_gain | 0.9800 |
| 1:45693203:GAT:G | acceptor_gain | 0.9700 |
| 1:45693192:T:G | acceptor_gain | 0.9300 |
| 1:45690972:A:AG | acceptor_gain | 0.9200 |
| 1:45690973:G:GG | acceptor_gain | 0.9200 |
| 1:45693203:GATA:G | acceptor_gain | 0.9200 |
| 1:45688255:C:T | donor_gain | 0.9100 |
| 1:45688309:T:TA | donor_gain | 0.9100 |
| 1:45688310:A:AA | donor_gain | 0.9100 |
| 1:45688158:G:GT | donor_gain | 0.8900 |
| 1:45688189:G:GT | donor_gain | 0.8900 |
| 1:45690973:GAAAC:G | acceptor_gain | 0.8900 |
| 1:45693203:GA:G | acceptor_gain | 0.8800 |
| 1:45688226:T:TA | donor_gain | 0.8700 |
| 1:45693203:GATAC:G | acceptor_gain | 0.8200 |
| 1:45693184:T:TA | acceptor_gain | 0.8100 |
| 1:45689000:TTC:T | donor_gain | 0.7800 |
| 1:45689067:C:G | donor_gain | 0.7600 |
| 1:45693191:A:AG | acceptor_gain | 0.7400 |
| 1:45690973:GA:G | acceptor_gain | 0.7300 |
| 1:45691105:TCAAA:T | donor_loss | 0.7200 |
| 1:45691106:CAAAG:C | donor_loss | 0.7200 |
| 1:45691107:AAAG:A | donor_loss | 0.7200 |
AlphaMissense
1603 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:45693564:A:C | S135R | 0.988 |
| 1:45693566:T:A | S135R | 0.988 |
| 1:45693566:T:G | S135R | 0.988 |
| 1:45693594:T:A | W145R | 0.979 |
| 1:45693594:T:C | W145R | 0.979 |
| 1:45693654:A:C | S165R | 0.978 |
| 1:45693656:T:A | S165R | 0.978 |
| 1:45693656:T:G | S165R | 0.978 |
| 1:45693678:T:A | W173R | 0.970 |
| 1:45693678:T:C | W173R | 0.970 |
| 1:45693600:T:C | F147L | 0.961 |
| 1:45693602:T:A | F147L | 0.961 |
| 1:45693602:T:G | F147L | 0.961 |
| 1:45693789:T:A | W210R | 0.951 |
| 1:45693789:T:C | W210R | 0.951 |
| 1:45693576:T:C | F139L | 0.950 |
| 1:45693578:C:A | F139L | 0.950 |
| 1:45693578:C:G | F139L | 0.950 |
| 1:45693438:A:C | S93R | 0.947 |
| 1:45693440:C:A | S93R | 0.947 |
| 1:45693440:C:G | S93R | 0.947 |
| 1:45693735:G:C | G192R | 0.946 |
| 1:45693596:G:C | W145C | 0.938 |
| 1:45693596:G:T | W145C | 0.938 |
| 1:45693555:T:G | Y132D | 0.936 |
| 1:45693736:G:A | G192D | 0.935 |
| 1:45693505:T:G | M115R | 0.928 |
| 1:45693597:G:C | G146R | 0.927 |
| 1:45693685:C:A | A175D | 0.924 |
| 1:45693559:G:A | G133E | 0.920 |
dbSNP variants (sampled 300 via entrez): RS1000154561 (1:45687547 G>C,T), RS1000540441 (1:45692377 A>AT), RS1000574232 (1:45691411 C>T), RS1000658036 (1:45692115 C>A,G,T), RS1001023908 (1:45686704 A>G), RS1001855994 (1:45686965 C>G,T), RS1001990501 (1:45686767 G>A,C), RS1002451210 (1:45692975 G>A), RS1002646293 (1:45689034 G>A), RS1002920718 (1:45691569 G>A), RS1003030075 (1:45691820 G>A), RS1003088194 (1:45686325 C>A,T), RS1003477400 (1:45686984 C>T), RS1003532308 (1:45688027 G>C), RS1003668178 (1:45687853 G>A,C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_37 | Body mass index | 8.000000e-10 |
| GCST009391_1592 | Metabolite levels | 5.000000e-06 |
| GCST010696_7 | Cortical thickness (min-P) | 3.000000e-08 |
| GCST010697_28 | Cortical surface area (min-P) | 2.000000e-08 |
| GCST010698_30 | Subcortical volume (min-P) | 3.000000e-08 |
| GCST010699_45 | Brain morphology (min-P) | 3.000000e-08 |
| GCST010700_23 | Cortical thickness (MOSTest) | 1.000000e-10 |
| GCST010701_9 | Cortical surface area (MOSTest) | 2.000000e-08 |
| GCST010702_139 | Subcortical volume (MOSTest) | 4.000000e-14 |
| GCST010703_258 | Brain morphology (MOSTest) | 2.000000e-13 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0010376 | phosphatidylcholine 34:2 measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| Air Pollutants | decreases expression, affects expression, increases abundance | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Lead | affects expression | 1 |
| Nickel | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2IU | Abcam HeLa TMEM69 KO | Cancer cell line | Female |
| CVCL_B5L4 | HAP1 TMEM69 (-) 2 | Cancer cell line | Male |
| CVCL_XU53 | HAP1 TMEM69 (-) 1 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.